Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S4W-05367 · Session 4

Further to the answer to question S4W-03307 by Nicola Sturgeon on 2 November 2011, what the timescale is for the review of the evidence on …

Answered Asked by Jackson Carlaw Con Lodged 31 Jan 2012

The question

To ask the Scottish Executive, further to the answer to question S4W-03307 by Nicola Sturgeon on 2 November 2011, what the timescale is for the review of the evidence on transcatheter aortic valve implantation and what steps are being taken to ensure that it takes account of (a) the updated guidance from the National Institute for Health and Clinical Excellence (NICE), (b) the health technology assessment commissioned by the National Institute for Health Research and (c) findings in peer-reviewed medical journal articles that the intervention is cost effective in high-risk patients for whom traditional open-heart surgery is not appropriate.

The answer

Answered by Nicola Sturgeon on 15 Feb 2012 · 15 days after it was lodged, 1 day after it was due

The National Planning Forum will consider both the updated guidance from the National Institute for Health and Clinical Excellence (NICE), and the health technology assessment (HTA) on TAVI commissioned by the National Institute for Health Research as soon as they are published.
NICE has indicated that it expects the Interventional Procedures Programme (IPP) guidance on TAVI to be published before the end of March 2012.
The National Institute for Health Research has indicated that the HTA has been extended in scope to also examine the cohort of people who are eligible for surgery, but are considered high risk. As a result, the HTA is now expected to be published later this summer.
As indicated in the answer to question S4W-03307 on 2 November 2011, the Scottish Health Technologies Group has robust processes in place for monitoring and reviewing publications relating to TAVI.
In the interim, NHS boards continue to ensure that local arrangements are in place so that people with severe aortic stenosis get access to appropriate clinical treatment. As part of those arrangements, where it is considered clinically appropriate by their doctors, people can get access to TAVI treatment through consideration by an individual case panel.
All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.scottish.parliament.uk/parliamentarybusiness/28877.aspx.

In the Official Report

No contribution in the Official Report cites S4W-05367 by reference.